Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Eyelten Therapeutics

Eyelten Therapeutics
2009 FOUNDED
OOB STATUS
1-10 EMPLOYEES
Out of Business LATEST DEAL TYPE
Description

Provider of pharmaceutical therapies for the treatment macular degeneration. The company offers medical preparations and treatment options for macular degeneration and other age related problems.

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 4041 Forest Park Avenue
  • Saint Louis, MO 63108
  • United States

+1 (314) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Eyelten Therapeutics’s full profile, request a free trial.

Eyelten Therapeutics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Out of Business Completed Out of Business
1. Early Stage VC Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Eyelten Therapeutics Executive Team (1)

Name Title Board
Seat
Contact
Info
Kunal Rehani President